FDA Sentinel Program Increases Adverse Event Reporting By User Facilities
This article was originally published in The Gray Sheet
Executive Summary
The average level of medical device adverse event reporting increased significantly under FDA's one-year Sentinel feasibility study concluded last year, according to a report submitted June 16 by Coda, the contractor organization facilitating the pilot.
You may also be interested in...
MeDSuN Pilot Funding Included In Budget; Program To Begin In Six Months
Funded at $1.7 mil. in FDA's FY 2001 budget, the Medical Device Surveillance Network (MeDSuN) reporting system pilot is expected to become operational within six months, according to Center for Devices and Radiological Health Office of Surveillance and Biometrics Deputy Director Susan Gardner.
MeDSuN Pilot Funding Included In Budget; Program To Begin In Six Months
Funded at $1.7 mil. in FDA's FY 2001 budget, the Medical Device Surveillance Network (MeDSuN) reporting system pilot is expected to become operational within six months, according to Center for Devices and Radiological Health Office of Surveillance and Biometrics Deputy Director Susan Gardner.
National Surveillance Network Would De-Identify Adverse Events Via 3rd Party
Adverse event data would be de-identified by a third-party before submission to FDA under the agency's proposed pilot reporting system, according to Center for Devices and Radiological Health (CDRH) Office of Surveillance and Biometrics Deputy Director Susan Gardner.